Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood

By De Wit D.   Tonon S.   Olislagers V.   Goriely S.   Boutriaux M.   Goldman M.   Willems F.  

Journal of Autoimmunity, Vol. 21, Iss. 3, 2003-11 ,pp. : 277-281

Elsevier

Access to resources Recommend Favorite

Skin-induced tolerance and its reversal by Toll-like receptor ligands

By Szczepanik Marian  

Archivum Immunologiae et Therapiae Experimentalis, Vol. 55, Iss. 3, 2007-06 ,pp. : 161-172

Springer Publishing Company

Access to resources Recommend Favorite

Toll-like receptor-mediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus

By Han S.B.   Yoon Y.D.   Ahn H.J.   Lee H.S.   Lee C.W.   Yoon W.K.   Park S.K.   Kim H.M.  

International Immunopharmacology, Vol. 3, Iss. 9, 2003-09 ,pp. : 1301-1312

Elsevier

Access to resources Recommend Favorite

Do microbes influence the pathogenesis of allergic diseases? Building the case for Toll-like receptor ligands

By Horner A.A.   Raz E.  

Current Opinion in Immunology, Vol. 15, Iss. 6, 2003-12 ,pp. : 614-619

Elsevier

Access to resources Recommend Favorite

TAK1 contributes to the enhanced responsiveness of LTB 4 -treated neutrophils to Toll-like receptor ligands

By Gaudreault Éric  

International Immunology, Vol. 24, Iss. 11, 2012-11 ,pp. : 693-704

Oxford University Press

Access to resources Recommend Favorite